Celloram

Celloram is a preclinical-stage company founded in 2018. Our team of experienced leaders and scientists is dedicated to improving the health and well-being of patients and families affected by cancer and chronic diseases. Celloram has a profound sense of social responsibility. We are committed to the communities where we live and work, fulfilling our commitment to promote diversity by inspiring, educating, and nurturing the next generation of scientists and leaders. Celloram is now leveraging its significant discoveries to develop unique forms of cell therapy and small molecule therapies, harnessing the body’s own unique potential to treat and combat chronic conditions, including cancer, autoimmune diseases, chronic inflammation, and metabolic disorders.